Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation (COMPAR-MI)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Libourne, France
- CH Libourne
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions.
- Major patients
- Patients not opposed to their participation in the study
Exclusion Criteria:
- Patients requiring conventional surgical revascularization.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Procedures with EndoNaut
|
Creation of a bone and arterial panorama using EndoNaut® software.
The routine care procedure begins with staged injections of contrast medium to provide a map of the lesions.
The lesions are then treated by angioplasty with or without stenting.
|
|
Procedures without Endonaut
|
Creation of a bone and arterial panorama using EndoNaut® software.
The routine care procedure begins with staged injections of contrast medium to provide a map of the lesions.
The lesions are then treated by angioplasty with or without stenting.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Volume of contrast product used during the routine care procedure (ml)
Time Frame: 1 day At enrollment
|
Volume are reported in mL
|
1 day At enrollment
|
|
Irradiation parameters: evaluation of the Fluoroscopy duration (min)
Time Frame: 1 day At enrollment
|
Parameter given by the X-ray imaging device
|
1 day At enrollment
|
|
Irradiation parameters: dose-area quantification (mGy/m2)
Time Frame: 1 day At enrollment
|
Parameter given by the X-ray imaging device
|
1 day At enrollment
|
|
Irradiation parameters: measurement of air Kerma (mGy)
Time Frame: 1 day At enrollment
|
Parameter given by the X-ray imaging device
|
1 day At enrollment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 001 (Marta Eliza Miller Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.